Pathologic findings, lectin histochemistry, and nuclear estrogen receptors were studied in the reproductive organs of gilts treated with clenbuterol. A ration containing 1 ppm of clenbuterol was fed for 40 days to four Landrace x Large white, 9-month-old gilts, weighing 134 to 172 kg at slaughter . Four gilts (Nos. 1-4) served as controls. Treated animals had macroscopic lesions characterized by microcystic ovaries and uterine atrophy. Histopathologic lesions included atretic degeneration of many ovarian follicles, complete absence of functional corpora lutea, a reduction in the number of endometrial glands, and a decrease in cytoplasmic volume of endometrial and glandular epithelial cells. In ovaries, uterus, and vagina lectin histochemistry, performed with thirteen different biotinylated lectins, revealed a different staining distribution between control and treated gilts. The binding pattern of Ricinus coinrnunis agglutinin-I (RCA-I) and -11 in the ovaries of control gilts, displayed labeling of cytoplasm in theca interna cells of Graafian follicles. There was no labeling of the same cells in treated gilts. Labeling patterns with Grifonia sirnplicfolia agglutinin-I (GS-I), Phaseolus vulgaris agglutinin (PHA), RCA-I and RCA-I1 documented a difference in the vascularity of the theca interna between Graafian follicles of control and treated gilts. The GS-I and Ulex europaeus agglutinin-I (UEA-I) binding patterns in uterus and vagina of treated gilts when compared to control gilts suggested that there was a block of the cycling activity in the proliferative stage. Immunohistochemical staining for estrogen receptors in the endometrium was positive in all but one treated gilts, and negative to weakly positive in control gilts. Serum progesterone concentrations were decreased in treated animals when compared to control; estradiol concentrations were similar in both group of gilts. Cystic ovaries, uterine atrophy, and reduction in progesterone concentrations suggested that clenbuterol changed ovarian hormonal activity in treated animals.
Clenbuterol (4-amino-3,5-dichloro a(tert-butylamino)methylbenzyl alcohol) is a 62-agonist widely used in veterinary medicine as bronchodilator and as tocolytic agent in bovine obstetrics. 28 In animal production, administration of this drug, either orally or parenterally, reduces fat deposition up to 30% and increases carcass protein. 30 For that reason, clenbuterol is largely and illegally used in many countries as a partitioning agent to stimulate muscle growth, especially in cattle, pigs, and pou1t1-y.~ Therefore, the use of p2-agonists in animal production can be responsible for food poisoning in humans, as recently reported in SpainI6 and France.
Several experiments have been carried out to study the effects of some 02-agonists on growth performance in pigs. 3J8,27,31 Although particular attention has been A preliminary short communication on the results in this paper was presented at the 10th Congress of the European Society of Veterinary Pathology, 24-27 September 1990, Zurich, Switzerland. given to performance, carcass and meat quality, and growth and feed efficiency, little is known about genital lesions following administration of p2-agonists. In a study carried out in female rats,22 it has been shown that a p2-agonist, clenbuterol, causes uterine lesions characterized by hydrometra and glandular dilation. These lesions were associated with an increase in the number of endometrial estrogen receptors. In addition to the detrimental effects on reproductive organs, the lesions in the female reproductive system following p2agonist administration may be used as indicators of illegal treatment. 23 Lectins are sugar-binding proteins and glycoproteins of nonimmune origin, which agglutinate cells or precipitate glycoconjugates with saccharides of appropriate ~omplementarity.~ According to one of their main current applications, lectins at histochemical level have been widely used to localize and characterize glycoconjugates during normal and pathological conditions of several tissue^,^ including the response of respiratory epithelium to p2-agonist admini~tration.~~ 82 Definitions, origins, acronyms, concentrations, major sugar specification, and binding inhibitors of the lectins 
Lactose NeuNAc a-L-Fucose * Gal = galactose; GalNAc = N-acetyl-galactosamine; GlcNAc = N-acetyl-glucosarnine; Man = mannose; NeuNAc = acetyl-neuraminic acid.
To determine if the female porcine genital tract was a target of P2-agonists activity, clenbuterol was administered at anabolic dosages to finishing gilts. The lesions in the genital tract as well as the changes in lectin labeling patterns is treated and control gilts were then compared.
Materials and Methods
Eight Landrace x Large white gilts (weight 122.25 k 4.80 kg) were randomly assigned to one of two experimental groups receiving pelleted rations, containing either 0 (gilt Nos. 1-4) or 1 ppm (gilt Nos. 5-8) of clenbuterol hydrochloride (Sigma Chem Co., St. Louis, MO). The gilts were housed in two pens with slatted floors and were exposed to a natural photoperiod (about 12 hours light/dark cycle) and ambient temperature (22 k 2 C). Feed and water were provided ad libitum. Blood samples were collected after 0, 24, and 48 days of treatment in order to evaluate serum concentrations of estradiol and progesterone, using commercially available RIA kits (Double Antibody Estradiol and Progesterone Coat-A-Count, DPC, Los Angeles, CA). The manufacturer's instructions for the use of these kits were modified as follows: serum samples were pre-extracted with diethylether (1 : 5 ) , dried under a light stream of nitrogen, and then restored with phosphate buffer (0.01 M, pH 7.4). The latter procedure was performed to avoid cross-reactions occurring between porcine serum and the matrix of the human kits.
On the 48th day of treatment, gilts were euthanized and the ovaries and uteri were collected and weighed. The stage of the estrous cycle was determined on the basis of ovarian features according to Leiser et a1.I5 Samples taken from vagina, uterine body, uterine horns, and ovaries were either fixed in 4% buffered formaldehyde for histopathologic evaluation and lectin histochemistry or snap frozen in liquid nitrogen for nuclear estrogen receptor immunohistochemistry. The latter assay was performed on 4 pm frozen sections using a commercially available monoclonal antibody (ER-ICA, Abbot Labs, Chicago, IL) following manufacturer's in-structions. Briefly, endogenous peroxidase activity was blocked by incubation in a 3% hydrogen peroxide solution at 40 C followed by incubation with the primary antibody for 30 minutes at room temperature. After extensive washing with 0.01 M phosphate buffer saline (PBS) (pH 7.2), the sections were covered with the second antibody for 30 minutes, washed again with PBS and incubated with the peroxidase-antiperoxidase (PAP) complex for 30 minutes at room temperature. The sections were finally covered with a solution of 0.0 1% diaminobenzidine-hydrogen peroxide for 4 to 8 minutes.
For histopathologic evaluation, formalin-fixed, paraffinembedded 4 pm thick sections were stained with hematoxylin-eosin.
For lectin histochemistry, formalin-fixed, paraffin-embedded, 6-pm sections were deparaffinized and hydrated. Endogenous peroxidase activity was blocked by incubation in 3% hydrogen peroxide solution at 40 C. Slides were then immersed in 0.2% trypsin-calcium chloride solution for 20 minutes at 37.5 C, followed by a I-hour incubation at room temperature with one of thirteen different biotinylated lectins (Sigma Chemical, St. Louis, MO). The lectins used, their origins, acronyms, concentrations, major sugar specification, and binding inhibitors are summarized in Table 1 . After extensive washing in PBS solution, tissue sections were incubated with the avidin-biotin-peroxidase complex (Vector Labs, Burlingame, CA), 50 pl of So1.A and 50 pl of So1.B in 5 ml of PBS, for 30 minutes at room temperature. Finally, sections were covered with a solution of 0.01% diaminobenzidine-hydrogen peroxide for 4 to 8 minutes. Two different controls were used. Incubation of the lectins with 0.2 M solution of their corresponding blocking sugar (Sigma Chemical, St. Louis, MO) before application to the tissue sections served as a control for binding specificity. In addition, incubation with avidin-biotin-peroxidase alone served as a nonspecific negative control. Sections were counterstained with Harris' hematoxylin. Positive structures were demonstrated by the golden, dark-brown 3'd-diaminobenzidine tetrahydrochloride-hydrogen peroxide reaction product. Statistical evaluation of data (expressed as mean values t SEM) was done with the aid of a computer program'9 using the Student's t-test and the analysis of variance (ANOVA). When significant differences ( P < 0.05; P < 0.0 1; P < 0.00 1) were found, ANOVA was followed by use of the Duncan's multiple range test and in this instance the limit of significance was set at P < 0.05. Table 2 shows the estradiol and progesterone serum concentrations observed in treated and control gilts. A significant reduction (P < 0.05) in progesterone con-centrations was observed in gilts treated with clenbuterol after 24 and 48 days ( Table 2) when compared with controls, while estradiol concentrations were not affected.
Results

Estradiol and progesterone serum concentrations
Macroscopic findings
The ovaries of control gilts showed cycling activity characterized by the presence of follicles at different stages of maturation and of corpora lutea (Fig. 1) Table 3 ). In addition, In contrast, the ovaries of all clenbuterol-treated gilts had no corpora lutea and multiple small follicles ranging from 3 to 5 mm diameter, similar to those observed in prepubertal gilts (Fig. 2) .
A marked, but not significant, difference in the total weight of both ovaries between treated (mean values k SEM = 6.88 ? 0.67 g) and control gilts (13.47 -t 3.40 g) was evident. The weight of left ovaries of control gilts was significantly higher (P < 0.05) when compared with both left and right ovaries of treated gilts (Table 3 ). The mean weight of uteri of control gilts was 765.75 k 8 1.1 1 g, and the uteri were morphologically normal (Fig. 3) for the stage of ovarian activity. In treated gilts, the uterus weight (260.50 -t 25.95 g), as well as the uterus/body weight ratio (Table 3) , were significantly decreased (P < 0.0 1). In addition, the uteri had a thinner wall (Fig. 4 ) when compared to the control gilts.
There were no macroscopic lesions or secretions in the uterus, cervix, or vagina of treated gilts. All treated gilts had severe hoof lesions characterized by erosion, ulceration, and sole reddening.
Histopathologic findings
The histologic findings of the ovaries in control gilts were consistent with the changes reported in normal cycling activity20 and were in agreement with the macroscopic features and serum estradiol and progesterone concentrations ( Table 2 , 3). In contrast, the ovaries of all treated gilts had similar histopathologic changes that were characterized by the presence of multiple small follicular cysts and a total absence of functional corpora lutea. Areas of connective tissue, derived from old corpora lutea or atretic follicles, also were present.
The majority of antral follicles in treated gilts were atretic and had the same appearance as atretic follicles in control gilts, with degenerated granulosa cells floating in the fluid (Fig. 5) . The theca interna cells of Graaf- 
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Vet Pathol 31:1, 1994 Genital Lesions Induced by Clenbuterol 87 -ian follicles in treated gilts were spindle-shaped and small (Fig. 6 ) when compared to corresponding cells in Graafian follicles of control gilts (Fig. 7) . Vascularity of theca interna was poor in treated gilts when compared to that of control gilts (Fig. 6, 7) . The histology of the uterus of control gilts (Fig. 8, 9 ) correlated with the stage of the estrus cycle (Table 3 ). In treated animals, the endometrial mucosa was thin and had a marked reduction in the number of glands (Fig. lo) , appearing like the endometrium of prepubertal gilts. The height of the superficial and glandular mucosal epithelial cells was less than the control gilts and represented a reduction in cytoplasmic volume (F'ig. 1 I).
Vascularity of the endometrium in treated gilts was poor. There were no histologic differences between uterine horns and uterine body of control and treated gilts.
The histologic changes in the vaginal epithelium of control gilts was consistent with the stage of the sexual cycle. l 9 During the proliferative phase, 10-20 cell layers were present, whereas during the secretory phase the number of layers was reduced to 2-4. Histologic changes in the treated animals were consistent with the secretive stage and were characterized by the presence of few epithelial cell layers (up to four). No other noticeable changes were observed.
Lectin histochemistry
With five of the 13 lectins used, Griflonia simplicifolia agglutinin-I (GS-I), Phaseolus vulgaris agglutinin (PHA), Ricinus communis agglutinin-I (RCA-I), and -I1 (RCA-11), and Ulex europaeus agglutinin-I (UEA-I), a different binding distribution was seen between control and treated gilts.
In the ovaries of control gilts, the binding pattern of some lectins discriminated between theca interna (thecal gland) cells of Graafian (polyhedral-shaped) and atretic (spindle-shaped) follicles. RCA-I and RCA-I1 labeled diffusely staining in the perinuclear cytoplasm of theca interna cells of Graafian follicles (Fig. 12 ). There was no cytoplasmic staining oftheca interna cells of atretic follicles. In treated animals, the RCA-I and RCA-I1 binding pattern on theca interna cells of Graafian and atretic follicles was identical to that seen in the atretic follicles of control gilts.
Capillaries located at the external site of the follicular basal lamina of Graafian follicles of control gilts were strongly labeled with GS-I, PHA, RCA-I and RCA-I1 (Fig. 12, 13) . The same lectins documented a decreased number of capillaries in atretic follicles of control gilts and in the Graafian and atretic follicles of treated gilts (Fig. 14) .
One of the 13 lectins, UEA-I, discriminated between the proliferative and the secretory stages of glandular and endometrial epithelium. During the proliferative stage in control gilts, UEA-I labeled the epithelial cells of uterine glands as well as the endometrial epithelium (Fig. 19 , whereas in the secretive stage, the epithelial cells of deeper glands were not stained (Fig. 16) . In treated gilts, the UEA-I binding pattern was comparable to that observed in the proliferative stage of control gilts.
Two of the 13 lectins, UEA-I and GS-I, discriminated between the proliferative and secretive stages of vaginal epithelium in control gilts. In the proliferative stage, UEA-I labeled only the upper cell layers (Fig.  17) , whereas in the secretory stage all the cell layers were stained (Fig. 18) . In treated gilts, the UEA-I binding pattern was similar to that of proliferative stages (Fig. 19) .
GS-I stained all the epithelial layers except the outermost (Fig. 20) in the proliferative stage, whereas in the secretory stage all cell layers were labeled (Fig. 2 1) . In treated gilts, the GS-I binding pattern was similar to that of proliferative stages (Fig. 22 ).
Irnrnunohistochemistry for estrogen receptors (ER)
Nuclear estrogen receptors detected by the immunoperoxidase reaction in endometrial surfaces, glandular epithelial cells, and interstitial mesenchymal cells had a moderately positive reaction in all control gilts ( Fig. 23) , except one which was negative. Labeling of the same structures was positive to strongly positive ( Fig. 24 ) in all treated gilts, except one which was negative (Table 3) .
Discussion
The results of this study show that long-term clenbuterol administration in finishing gilts causes lesions in the reproductive system, and induces an alteration of the cycling activity. Genital tract lesions following long-term clenbuterol administration have been reported in rats2,22 and in Rats showed hydrometra and endometrial gland dilation associated with c Fig. 9.   Fig. 10 . Fig. 14.   Fig. 15.   Fig. 16 . a significant increase in uterine estrogen receptor content. The vagina and uterus of veal calves showed an abnormal collection of mucus, endometrial gland dilation, and microcystic ovaries associated with high concentrations of uterine estrogen and progesterone receptors.
Although the pathological changes in these species are different from those observed in the gilts in this experiment (i.e., small multiple follicular cysts, uterine and vaginal atrophy), it seems evident that the reproductive system is a target of clenbuterol action.
From the pathogenetic point of view, the most important finding appears to be the ovarian microcystic degeneration, which possibly causes a condition of altered hormonal production. This hypothesis is in agreement with the serum progesterone concentrations observed in treated gilts at day 48 (Table 2 ). The results of our study are consistent with an alteration in ovarian activity affecting mainly progesterone production, whereas in control gilts the results indicate a normal cycling activity.I9 Interestingly, the progesterone concentrations of treated animals were significantly low- Hypotheses for the mechanism of action of P2-agonists on the female reproductive system suggest a direct peripheral ovarian involvement. P2-receptors are well known to be present at different areas of the female genital tract (e.g., myometrium, smooth muscle cells of vessels, granulosa cells). 13~14. 26 We had observed in previous experiments in rats that the concomitant administration of a P2-blocking agent (propranolol) inhibits the development of the typical genital tract lesions and the increase in receptor concentrations because of long-term treatment with c l e n b~t e r o l .~~ Consequently, it may be hypothesized that the intense stimulation of the 02-adrenergic receptors induces genital lesions and increases the concentration of uterine estrogen receptors in gilts. Moreover, it has been shown recently that CAMP, whose target cell concentrations rise sharply after P2-adrenergic stimulation,'* is able to interfere with sex hormone mechanism of action in vitro.'j Other reports suggest that clenbuterol can interfere with FSH and LH action on Graafian follicles. It is noteworthy that, in vivo, the gonadotrophins FSH and LH, the primary protein hormones involved in folliculogenesis," enhance steroidogenic activity in granulosa and theca interna cells by activating CAMPdependent processes. I 3 Sustained high gonadotrophin concentration or slow rates of dissociation from their receptors result in abrogation of the receptor-adenylate-CAMP response systemi4 and a desensitization of the adenylate cyclase in follicular cells to further gonadotrophin s t i m~l a t i o n .~ Because granulosa cells possess P2-agonist receptors,13 it is possible that another consequence of chronic clenbuterol administration is a down-regulation of the adenylate cyclase-CAMP system in granulosa cells resulting in desensitization of these cells to gonadotrophin action. The final effect of all these mechanisms is a lowered hormonal production leading to the presence of antral nondominant follicles. 26 In our experiment, the latter hypothesis is supported by the observation that the serum progesterone concentrations are lower than those of control animals, whereas nuclear estrogen receptors, revealed immunohistochemically, were markedly increased in clenbuterol treated animals. Furthermore, the histopathological evaluation ofGraafian follicles in treated animals revealed that the morphology of theca interna cells (spindle-shaped) is consistent with an alteration of steroidogenesis leading to abnormal hormonal concentrations.'O In addition to these findings, lectin histochemistry showed a lack of RCA-I and RCA-I1 binding sites in the theca interna cells of Graafian follicles of treated gilts. In a quantitative study on rat luteal cells, it has been shown that there is a close relationship between progesterone secretion and the portion of the cytoplasm occupied by smooth endoplasmic reticulum (SER).17 Because RCA-I and RCA-I1 staining was located in the part of the cytoplasm that in steroidogenic cells is occupied by SER, we presume that the presence or the lack of RCA-I and RCA-I1 binding sites may be related to high and low amounts of smooth endoplasmic reticulum, respectively, and therefore to the level of steroidogenic activity.I7
Another hypothesis may be proposed by the poor perfusion following the reduction of vascularization which, as confirmed by GS-I and PHA lectin binding pattern, may also be a consequence of the adrenergic stimulation in treated gilts. Consequently, vascular changes could be responsible for follicular atresia and for reduction or lack of theca interna and granulosa cell hormonal activity, as well as for the hoof lesions observed in treated gilts.31 These data could be related to the characteristic vascular response of swine to intense adrenergic stimu1ation.I HE-stained sections of vaginal epithelium could not be used to differentiate between a secretory stage in control animals and the pattern observed in treated gilts. By contrast, the UEA-I and GS-I lectin binding patterns in treated gilts were similar to the proliferative stage in control animals. This may be explained by the relatively higher serum estradiol concentrations as compared to progesterone concentrations in the treated group. The same hypothesis can be formulated for the uterus where the lectin binding pattern of endometrial gland cells was characteristic of proliferative stage. Atrophic changes were more evident, however, than was a clear, histologically defined stage of sexual cycle.
